Sign In
Buy PFE
$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
Pfizer: The Market Is Still Wrong About It
09:00am, Friday, 05'th Dec 2025
Pfizer's stock rebounded from April lows yet still trades as if COVID and patent cliffs equal business ruin, despite resilient non‑COVID franchises and pipeline optionality. Q3 looked weak, with rev
First Look: Netflix buys WBD, Meta cuts metaverse, Cloudflare outage
07:38am, Friday, 05'th Dec 2025
Stock News EU issues first DSA penalty to X: The European Commission fined X â¬120 million for deceptive blue-check design and ad/research transparency failure
Market Today: WBD Sale Bids, Meta Cuts, Apple Shake-Up
05:33pm, Thursday, 04'th Dec 2025
Stock News WBD sale draws scrutiny as Netflix leads: Warner Bros. Discovery (WBD) received second-round offers with Netflix (NFLX) reportedly the leading bidder
Pfizer (PFE) Up 3.9% Since Last Earnings Report: Can It Continue?
12:36pm, Thursday, 04'th Dec 2025
Pfizer (PFE) reported earnings 30 days ago. What's next for the stock?
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (December 2025)
08:00am, Thursday, 04'th Dec 2025
Shares of Pfizer ( NYSE: PFE ) gained 3.69% over the past month after gaining 9.90% the month prior.
First Look: Insurers, Auto Rules, AI and Fed Jitters
07:38am, Thursday, 04'th Dec 2025
Stock News Insurers under pressure, prior auth pledges stall: UnitedHealth Group (UNH) and peers Cigna (CI), Humana (HUM), CVS Health (CVS) and Elevance Health
3 Potential Mid-Cap Biotech Buyout Targets In 2026
06:22pm, Wednesday, 03'rd Dec 2025
The biotech sector began December with notable weakness, as both IBB and XBI ETFs declined over two percent during trading on Monday. The sector has bounced back since. However, small biotech stocks
17 dividend-stock bargains from a value manager with a stellar track record
12:11pm, Tuesday, 02'nd Dec 2025
John Buckingham, editor of the Prudent Speculator, reminds investors to be “willing to stomach volatility.”
Pfizer's Cancer Drugs Deliver Growth Amid Competitive Pressure
11:26am, Tuesday, 02'nd Dec 2025
Pfizer's expanding oncology portfolio, rising sales of key therapies, and steady pipeline progress reinforce its long-term cancer strategy momentum.
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
10:01am, Tuesday, 02'nd Dec 2025
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
Our December High-Yield 6% Dividend Stocks Have Big Total Return Potential
08:42am, Tuesday, 02'nd Dec 2025
Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential.
Beacon Pointe Advisors LLC Sells 607,423 Shares of Pfizer Inc. $PFE
05:18am, Tuesday, 02'nd Dec 2025
Beacon Pointe Advisors LLC decreased its holdings in shares of Pfizer Inc. (NYSE: PFE) by 40.0% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and
Dow Jones Today: Stock Indexes Close Lower to Begin December Trading; Big Tech, Crypto-Tied Shares Drop Amid Risk-Off Sentiment
08:00pm, Monday, 01'st Dec 2025
Major stock indexes pulled back as the final trading month of the year began, with shares of big tech and cryptocurrency-tied firms falling amid risk-off sentiment.
Market Today: Crypto Rout, Omnicom Cuts, Nvidia--Synopsys Deal
06:17pm, Monday, 01'st Dec 2025
Guru Stock PicksRoyce International Premier Fund has made the following transactions:Reduce in XTER: EVD by 0.78%Sold out in ASX:JLGAdd in XPAR: PLNW by 62.41%New
FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks
03:50pm, Monday, 01'st Dec 2025
A report that vaccine approvals could be set to get stricter is pressuring shares of major vaccine makers.
